Jianrong Wang
Research Subjects
Jianrong Wang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Baodui Wang
College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China
2 shared publications Hongfang Zhao
Gansu Provincial Maternity and Child-care Hospital (Gansu Provincial Central Hospital), Department of Oral Healthcare, 730050, Lanzhou, P. R. China
2 shared publicationsPing Huang
Gansu Provincial Maternity and Child-care Hospital (Gansu Provincial Central Hospital), Department of Oral Healthcare, 730050, Lanzhou, P. R. China
2 shared publicationsYan Jiao
Gansu Rehabilitation Center Hospital, 730030, Lanzhou, P. R. China
2 shared publicationsDuhong Li
Gansu Provincial Maternity and Child-care Hospital (Gansu Provincial Central Hospital), Department of Oral Healthcare, 730050, Lanzhou, P. R. China
1 shared publicationShuheng Yang
School/Hospital of Stomatology Lanzhou University, Lanzhou 730000, China
1 shared publication
Latest Publications
- 12 October 2026
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 50 (39) , 17184-17195
Multi-level performance optimization and bone defect repair using a yak bone derived hydroxyapatite/chitosan scaffold material
Biomaterials possessing distinct biomimetic structures, hydroxyapatite (HAP) and chitosan (CS), demonstrate potential in the biochemical regulation and construction of a biophysical microenvironment for bone repair.
- 12 October 2026
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 50 (39) , 17184-17195
Multi-level performance optimization and bone defect repair using a yak bone derived hydroxyapatite/chitosan scaffold material
Biomaterials possessing distinct biomimetic structures, hydroxyapatite (HAP) and chitosan (CS), demonstrate potential in the biochemical regulation and construction of a biophysical microenvironment for bone repair.
- 8 January 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (4) , 1342-1351
Regulation of bone regeneration by chiral modified hydroxyapatite/chitosan scaffolds
Chirality is ubiquitous in nature, from the macroscopic to the microscopic. Natural bone has good hardness and toughness. It is composed of collagen and minerals and has chiral structures from the atomic scale to the macroscopic scale. It plays an important role in regenerative medicine. The design of bone-inspired bioscaffolds focuses on the surface roughness, three-dimensional structure and layered structure of the scaffold in order to build a microenvironment that is closest to the biological bone structure. However, the current bone repair materials do not reflect chiral structures. Therefore, this work selected lanthanum-doped hydroxyapatite/chitosan as the raw material, and added different percentages (10%, 30%, 50%, 70%, and 90%) of poly(L-lactide) (PLLA) to synthesize PLLHC-0, PLLHC-1, PLLHC-3, PLLHC-5, PLLHC-7 and PLLHC-9 chiral scaffold materials. Cell experiments have demonstrated that the cell survival rate and the relative activity of ALP at days 1, 7, and 14 in the PLLHC-5 scaffold group are 99.4%, 7.06, 8.64, and 11.84, respectively. In animal models, micro-CT analysis at 8 weeks showed that the BV/TV (%) of PLLHC-5 at 4 and 8 weeks reached 89.33% and 95.13%, which were significantly higher than those in other groups. All PLLHC-X scaffolds exhibited gradual degradation in vivo, while strongly promoting new bone formation and effective bone tissue repair. These results demonstrate that the PLLHC-5 scaffold exhibits the strongest osteogenic capability and represents a promising novel material for bone regeneration.
- 8 January 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (4) , 1342-1351
Regulation of bone regeneration by chiral modified hydroxyapatite/chitosan scaffolds
Chirality is ubiquitous in nature, from the macroscopic to the microscopic. Natural bone has good hardness and toughness. It is composed of collagen and minerals and has chiral structures from the atomic scale to the macroscopic scale. It plays an important role in regenerative medicine. The design of bone-inspired bioscaffolds focuses on the surface roughness, three-dimensional structure and layered structure of the scaffold in order to build a microenvironment that is closest to the biological bone structure. However, the current bone repair materials do not reflect chiral structures. Therefore, this work selected lanthanum-doped hydroxyapatite/chitosan as the raw material, and added different percentages (10%, 30%, 50%, 70%, and 90%) of poly(L-lactide) (PLLA) to synthesize PLLHC-0, PLLHC-1, PLLHC-3, PLLHC-5, PLLHC-7 and PLLHC-9 chiral scaffold materials. Cell experiments have demonstrated that the cell survival rate and the relative activity of ALP at days 1, 7, and 14 in the PLLHC-5 scaffold group are 99.4%, 7.06, 8.64, and 11.84, respectively. In animal models, micro-CT analysis at 8 weeks showed that the BV/TV (%) of PLLHC-5 at 4 and 8 weeks reached 89.33% and 95.13%, which were significantly higher than those in other groups. All PLLHC-X scaffolds exhibited gradual degradation in vivo, while strongly promoting new bone formation and effective bone tissue repair. These results demonstrate that the PLLHC-5 scaffold exhibits the strongest osteogenic capability and represents a promising novel material for bone regeneration.